Maria Magdelena Tamas

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

Zara Izadi, Milena Gianfrancesco, Gabriela Schmajuk, Lindsay Jacobsohn et autres

us, de, pt, gb, fr, es, qa, pe, se, it, ar, br, au, ca, nz (code pays fourni par la source)

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry

Richard Conway, Elena Nikiphorou, Christiana A. Demetriou, Candice Low et autres

OBJECTIVES: Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for people with rheumatic disease in Ireland. METHODS: Data …

ie, gb, cy, au, us, nz (code pays fourni par la source)

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, R C Conway, Michael Putman et autres

BACKGROUND: Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We …

us, ie, au, gb, ar, br, se, it, fr, de, pt, qa, pe, es, ca, nz (code pays fourni par la source)

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil, Nick Dand et autres

Importance: Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally because of their ability to ameliorate shared immune pathways across immune-mediated inflammatory diseases (IMIDs), the impact of COVID-19 among individuals with IMIDs who are receiving TNF inhibitors remains insufficiently understood. Objective: …

us, gb, de, es, pt, ch, se, it, qa, ar, br, fr, nz, ca, au (code pays fourni par la source)